Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
about
Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response.Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel.AKT/ERK activation is associated with gastric cancer cell resistance to paclitaxel.E1a promotes c-Myc-dependent replicative stress: implications in glioblastoma radiosensitization.Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways.Characteristics of doxorubicin-selected multidrug-resistant human leukemia HL-60 cells with tolerance to arsenic trioxide and contribution of leukemia stem cells.Using phosphine ligands with a biological role to modulate reactivity in novel platinum complexes.CMPD1 inhibited human gastric cancer cell proliferation by inducing apoptosis and G2/M cell cycle arrest.XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells
P2860
Q35497999-7B0F7F23-1BAB-447F-A9D1-F64BC4953B53Q38379668-68E6E8F9-1CFA-43E6-97BD-D4A0650CBD00Q38781057-9CB77432-6BB4-42E5-A918-0426995F66F4Q38996033-939124B2-14E0-40E8-948D-1F15A13BF56EQ39066576-BC4BD3B7-C3D2-4C69-AB0B-6B53D1492391Q46976280-30AB6475-AF7C-446C-93C8-53361652CF9EQ49334989-2003F964-F84C-4106-A284-5E9BBF0DE3AEQ52363628-CCF1BE8C-1E1B-4072-ACE4-6D3EF37086E7Q52585066-181BCF9E-1C75-4FFF-B9F6-24C250637813Q58606469-468D21AF-9929-4C99-93A4-D25E9D611D36
P2860
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
@en
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
@nl
type
label
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
@en
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
@nl
prefLabel
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
@en
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
@nl
P2093
P2860
P1433
P1476
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair
@en
P2093
A Gutiérrez-González
G Dominguez
J Bargiela-Iparraguirre
P García Alfonso
P2860
P2888
P304
P356
10.1007/S10495-012-0794-2
P577
2013-03-01T00:00:00Z